Agrochemical giant Monsanto is set to be acquired by Bayer — the largest acquisition so far this year.
The German chemical and pharmaceutical company, best known in the U.S. for its aspirin, announced the deal Wednesday, raising its initial offer for a third time to $66 billion, including debt.
Here & Now's Jeremy Hobson speaks with Nathan Bomey of USA Today about the implications of the deal and how analysts are reacting.
This segment aired on September 14, 2016.
- Chemical Giant Bayer Agrees To Buy Monsanto For $66 Billion
- Monsanto CEO: 'Roundup Is Not A Carcinogen'
- Monsanto CEO Talks Crops, Pesticides And Farms
- Fact And Fiction About Monsanto
- A Look At Billion-Dollar Deals For ChemChina And Pfizer